DMAC vs XRAY · $157.4M cap vs rev $3.68B
DiaMedica Therapeutics Inc (DMAC) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
DMAC does not have a complete income-statement cache yet.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
DMAC currently screens at market cap $157.4M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the DMAC and XRAY stock pages for the full models.
Not investment advice.